Literature DB >> 12574272

Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum.

Robert F Massung1, Kimetha G Slater.   

Abstract

Human granulocytic ehrlichiosis is an emerging infectious disease in the United States and Europe, and PCR methods have been shown to be effective for the diagnosis of acute infections. Numerous PCR assays and primer sets have been reported in the literature. The analytical sensitivities (limits of detection) of 13 published PCR primer sets were compared using DNA extracted from serial dilutions of Anaplasma phagocytophilum-infected HL-60 cells. The specificity of the assays that were able to detect <or=2.5 infected cells was tested by the use of template DNA extracted from Ehrlichia chaffeensis, Rickettsia rickettsii, and Bartonella henselae. The assays with the lowest limits of detection were shown to be a nested assay that amplifies the 16S rRNA gene (primer pairs ge3a-ge10 [primary] and ge9-ge3 [nested]; detects 0.25 infected cell), a direct assay that amplifies the major surface protein gene msp2 (primer pair msp2-3f-msp2-3r; detects 0.25 infected cell), and a direct assay that amplifies the 16S rRNA gene (primer pair ehr521-ehr790; detects 0.25 infected cell). The specificity and limit of detection of the MSP2 and 16S rRNA direct assays were further tested by use of A. phagocytophilum template DNA from both North America and Europe and from human, tick, white-footed mouse, equine, deer, bovine, and wood rat samples and of template DNA from closely related species (Anaplasma marginale, the white-tailed deer agent, and additional E. chaffeensis-positive samples). Three manufacturers' PCR kits were tested and showed distinct variations in the limit of detection, specificity, and nonspecific background amplification. The importance of these results for the molecular diagnosis of human granulocytic ehrlichiosis is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574272      PMCID: PMC149680          DOI: 10.1128/JCM.41.2.717-722.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae.

Authors:  J J Walls; P Caturegli; J S Bakken; K M Asanovich; J S Dumler
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.

Authors:  M B Klein; C M Nelson; J L Goodman
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

3.  Transmission of the agent of human granulocytic ehrlichiosis by Ixodes spinipalpis ticks: evidence of an enzootic cycle of dual infection with Borrelia burgdorferi in Northern Colorado.

Authors:  N S Zeidner; T R Burkot; R Massung; W L Nicholson; M C Dolan; J S Rutherford; B J Biggerstaff; G O Maupin
Journal:  J Infect Dis       Date:  2000-07-28       Impact factor: 5.226

4.  Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila.

Authors:  J S Dumler; A F Barbet; C P Bekker; G A Dasch; G H Palmer; S C Ray; Y Rikihisa; F R Rurangirwa
Journal:  Int J Syst Evol Microbiol       Date:  2001-11       Impact factor: 2.747

5.  Experimental evidence of host specificity of Bartonella infection in rodents.

Authors:  M Y Kosoy; E K Saito; D Green; E L Marston; D C Jones; J E Childs
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2000-10       Impact factor: 2.268

6.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

Authors:  J E Dawson; B E Anderson; D B Fishbein; J L Sanchez; C S Goldsmith; K H Wilson; C W Duntley
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

8.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

10.  In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.

Authors:  P Brouqui; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

View more
  36 in total

1.  Elimination of Borrelia burgdorferi and Anaplasma phagocytophilum in rodent reservoirs and Ixodes scapularis ticks using a doxycycline hyclate-laden bait.

Authors:  Marc C Dolan; Terry L Schulze; Robert A Jordan; Gabrielle Dietrich; Christopher J Schulze; Andrias Hojgaard; Amy J Ullmann; Cherilyn Sackal; Nordin S Zeidner; Joseph Piesman
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Importance of primer specificity for PCR detection of Anaplasma phagocytophila among Ixodes scapularis ticks from Wisconsin.

Authors:  Sanjay K Shukla; Mary F Vandermause; Edward A Belongia; Kurt D Reed; Susan M Paskewitz; James Kazmierczak
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Anaplasma phagocytophilum infection in a domestic cat in Finland: Case report.

Authors:  Helka M Heikkilä; Anna Bondarenko; Andrea Mihalkov; Kurt Pfister; Thomas Spillmann
Journal:  Acta Vet Scand       Date:  2010-11-15       Impact factor: 1.695

4.  Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States.

Authors:  Alberto Alberti; Rosanna Zobba; Bernardo Chessa; Maria Filippa Addis; Olivier Sparagano; Maria Luisa Pinna Parpaglia; Tiziana Cubeddu; Gianpaolo Pintori; Marco Pittau
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

5.  Molecular method for identification of Rickettsia species in clinical and environmental samples.

Authors:  Isabel Jado; Raquel Escudero; Horacio Gil; María Isabel Jiménez-Alonso; Rita Sousa; Ana L García-Pérez; Manuela Rodríguez-Vargas; Bruno Lobo; Pedro Anda
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

6.  Anaplasma phagocytophilum in central and western Wisconsin: a molecular survey.

Authors:  M Michalski; C Rosenfield; M Erickson; R Selle; K Bates; D Essar; R Massung
Journal:  Parasitol Res       Date:  2006-11       Impact factor: 2.289

Review 7.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

8.  Detection and identification of Ehrlichia spp. in ticks collected in Tunisia and Morocco.

Authors:  M'Hammed Sarih; Youmna M'Ghirbi; Ali Bouattour; Lise Gern; Guy Baranton; Danièle Postic
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains.

Authors:  José de la Fuente; Robert F Massung; Susan J Wong; Frederick K Chu; Hans Lutz; Marina Meli; Friederike D von Loewenich; Anna Grzeszczuk; Alessandra Torina; Santo Caracappa; Atilio J Mangold; Victoria Naranjo; Snorre Stuen; Katherine M Kocan
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Multiplex real-time PCR for detection of anaplasma phagocytophilum and Borrelia burgdorferi.

Authors:  Joshua W Courtney; Leah M Kostelnik; Nordin S Zeidner; Robert F Massung
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.